Axcan (Photofrin and Photobarr) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Axcan (Photofrin and Photobarr) General Information

Description

A novel therapeutic technique approved for the treatment of non-small cell lung cancer (NSCLC) and esophageal cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 597 boulevard Laurier
  • Mont-Saint-Hilaire, Quebec J3H 6C4
  • Canada
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Pinnacle Biologics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 597 boulevard Laurier
  • Mont-Saint-Hilaire, Quebec J3H 6C4
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axcan (Photofrin and Photobarr) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axcan (Photofrin and Photobarr)‘s full profile, request access.

Request a free trial

Axcan (Photofrin and Photobarr) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Axcan (Photofrin and Photobarr)‘s full profile, request access.

Request a free trial

Axcan (Photofrin and Photobarr) FAQs

  • Where is Axcan (Photofrin and Photobarr) headquartered?

    Axcan (Photofrin and Photobarr) is headquartered in Mont-Saint-Hilaire, Canada.

  • What industry is Axcan (Photofrin and Photobarr) in?

    Axcan (Photofrin and Photobarr)’s primary industry is Buildings and Property.

  • Is Axcan (Photofrin and Photobarr) a private or public company?

    Axcan (Photofrin and Photobarr) is a Private company.

  • What is Axcan (Photofrin and Photobarr)’s current revenue?

    The current revenue for Axcan (Photofrin and Photobarr) is .

  • Who are Axcan (Photofrin and Photobarr)’s investors?

    Aptalis Pharma has invested in Axcan (Photofrin and Photobarr).

  • When was Axcan (Photofrin and Photobarr) acquired?

    Axcan (Photofrin and Photobarr) was acquired on 29-Mar-2011.

  • Who acquired Axcan (Photofrin and Photobarr)?

    Axcan (Photofrin and Photobarr) was acquired by Pinnacle Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »